These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38612817)

  • 21. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphine.
    Mizoguchi H; Bagetta G; Sakurada T; Sakurada S
    Peptides; 2011 Feb; 32(2):421-7. PubMed ID: 21126548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
    Linz K; Christoph T; Tzschentke TM; Koch T; Schiene K; Gautrois M; Schröder W; Kögel BY; Beier H; Englberger W; Schunk S; De Vry J; Jahnel U; Frosch S
    J Pharmacol Exp Ther; 2014 Jun; 349(3):535-48. PubMed ID: 24713140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
    Molinari S; Camarda V; Rizzi A; Marzola G; Salvadori S; Marzola E; Molinari P; McDonald J; Ko MC; Lambert DG; Calo' G; Guerrini R
    Br J Pharmacol; 2013 Jan; 168(1):151-62. PubMed ID: 22827708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.
    Lei W; Vekariya RH; Ananthan S; Streicher JM
    J Pain; 2020; 21(1-2):146-160. PubMed ID: 31201990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist-neurokinin 1 receptor antagonist chimera.
    Guillemyn K; Kleczkowska P; Novoa A; Vandormael B; Van den Eynde I; Kosson P; Asim MF; Schiller PW; Spetea M; Lipkowski AW; Tourwé D; Ballet S
    Mol Brain; 2012 Jan; 5():4. PubMed ID: 22289619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for
    Obeng S; Wilkerson JL; León F; Reeves ME; Restrepo LF; Gamez-Jimenez LR; Patel A; Pennington AE; Taylor VA; Ho NP; Braun T; Fortner JD; Crowley ML; Williamson MR; Pallares VLC; Mottinelli M; Lopera-Londoño C; McCurdy CR; McMahon LR; Hiranita T
    J Pharmacol Exp Ther; 2021 Mar; 376(3):410-427. PubMed ID: 33384303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
    Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment.
    Pasquinucci L; Parenti C; Turnaturi R; Aricò G; Marrazzo A; Prezzavento O; Ronsisvalle S; Georgoussi Z; Fourla DD; Scoto GM; Ronsisvalle G
    Life Sci; 2012 Jan; 90(1-2):66-70. PubMed ID: 22100511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activities of mixed NOP and mu-opioid receptor ligands.
    Spagnolo B; Calo G; Polgar WE; Jiang F; Olsen CM; Berzetei-Gurske I; Khroyan TV; Husbands SM; Lewis JW; Toll L; Zaveri NT
    Br J Pharmacol; 2008 Feb; 153(3):609-19. PubMed ID: 18059322
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Lattanzi R; Rief S; Schmidhammer H; Negri L; Spetea M
    Front Pharmacol; 2018; 9():1002. PubMed ID: 30233377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues.
    Marastoni M; Salvadori S; Balboni G; Borea PA; Marzola G; Tomatis R
    J Med Chem; 1987 Sep; 30(9):1538-42. PubMed ID: 2887656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coincident Regulation of PLC
    Sanchez GA; Jutkiewicz EM; Ingram S; Smrcka AV
    Mol Pharmacol; 2022 Dec; 102(6):269-279. PubMed ID: 36116788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.
    Riba P; Ben Y; Nguyen TM; Furst S; Schiller PW; Lee NM
    Curr Med Chem; 2002 Jan; 9(1):31-9. PubMed ID: 11860345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Huang P; Ho CK; Cao D; Inan S; Rawls SM; Li M; Huang B; Pagare PP; Townsend EA; Poklis JL; Halquist MS; Banks M; Zhang Y; Liu-Chen LY
    J Pharmacol Exp Ther; 2024 Feb; 389(1):106-17. PubMed ID: 38409113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat.
    Tejwani GA; Rattan AK
    Anesth Analg; 2002 Jun; 94(6):1542-6, table of contents. PubMed ID: 12032023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dual nociceptin and mu opioid receptor agonist exhibited robust antinociceptive effect with decreased side effects.
    Hsu YT; Chen SR; Chang YC; Chang HF; Yeh TK; Chuang JY; Loh HH; Hsieh HP; Ueng SH; Yeh SH
    Eur J Med Chem; 2023 Oct; 258():115608. PubMed ID: 37437352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
    Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
    Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic interaction between DAMGO-NH
    Li N; Xiao J; Niu J; Zhang M; Shi Y; Yu B; Zhang Q; Chen D; Zhang N; Fang Q
    Peptides; 2023 Mar; 161():170943. PubMed ID: 36621672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.